Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About the Ochsner Journal
    • Editorial Board
  • More
    • Alerts
    • Feedback
  • Other Publications
    • Ochsner Journal Blog

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Ochsner Journal
  • Other Publications
    • Ochsner Journal Blog
  • My alerts
  • Log in
Ochsner Journal

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About the Ochsner Journal
    • Editorial Board
  • More
    • Alerts
    • Feedback
Review ArticleReviews and Commentaries

Familial Hypercholesterolemia

Rade N. Pejic
Ochsner Journal December 2014, 14 (4) 669-672;
Rade N. Pejic
Department of Family Medicine, Tulane University School of Medicine, New Orleans, LA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Abstract

Background Familial hypercholesterolemia (FH) is an autosomal dominant-inherited genetic disorder that leads to elevated blood cholesterol levels. FH may present as severely elevated total cholesterol and low density lipoprotein (LDL) cholesterol levels or as premature coronary heart disease (CHD).

Methods This review presents information on the disease and on the effects of drug treatment and lifestyle changes.

Results Routine lipid testing should identify most patients with FH. Once an index case is identified, testing should be offered to family members. Early diagnosis and aggressive treatment with therapeutic lifestyle changes and statins can prevent premature CHD and other atherosclerotic sequelae in patients with FH.

Conclusion Emerging therapies such as LDL apheresis and novel therapeutic agents may be useful in patients with homozygous FH or treatment-resistant FH. Liver transplantation is the only effective therapy for severe cases of homozygous FH.

Keywords
  • Genetic diseases–inborn
  • hypercholesterolemia
  • hyperlipoproteinemia type II

Footnotes

  • The author has no financial or proprietary interest in the subject matter of this article.

  • © Academic Division of Ochsner Clinic Foundation
View Full Text
PreviousNext
Back to top

In this issue

Ochsner Journal
Vol. 14, Issue 4
Dec 2014
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Ochsner Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Familial Hypercholesterolemia
(Your Name) has sent you a message from Ochsner Journal
(Your Name) thought you would like to see the Ochsner Journal web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Familial Hypercholesterolemia
Rade N. Pejic
Ochsner Journal Dec 2014, 14 (4) 669-672;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Familial Hypercholesterolemia
Rade N. Pejic
Ochsner Journal Dec 2014, 14 (4) 669-672;
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • EPIDEMIOLOGY AND GENETICS
    • CLINICAL PRESENTATION AND DIAGNOSIS
    • TREATMENT
    • CONCLUSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Cited By...

  • Targeting the Liver with Nucleic Acid Therapeutics for the Treatment of Systemic Diseases of Liver Origin
  • Stability of extemporaneously prepared rosuvastatin oral suspension
  • Google Scholar

More in this TOC Section

  • Rhabdomyolysis: Pathogenesis, Diagnosis, and Treatment
  • iPhone and iPad Use in Orthopedic Surgery
  • Drug-Induced Acute Pancreatitis: A Review
Show more Reviews and Commentaries

Similar Articles

Keywords

  • genetic diseases–inborn
  • hypercholesterolemia
  • hyperlipoproteinemia type II

Ochsner Journal Blog

Current Post

Be Careful Where You Publish -- Part 2

Our Content

  • Home
  • Current Issue
  • Ahead of Print
  • Archive
  • Featured Contributors
  • Ochsner Journal Blog
  • Archive at PubMed Central

Information & Forms

  • Instructions for Authors
  • Instructions for Reviewers
  • Submission Checklist
  • FAQ
  • License for Publishing-Author Attestation
  • Patient Consent Form
  • Submit a Manuscript

Services & Contacts

  • Permissions
  • Sign up for our electronic table of contents
  • Feedback Form
  • Contact Us

About Us

  • Editorial Board
  • About the Ochsner Journal
  • Ochsner Health
  • University of Queensland-Ochsner Clinical School
  • Alliance of Independent Academic Medical Centers

© 2025 Ochsner Clinic Foundation

Powered by HighWire